Vertex Pharmaceuticals (VRTX) Free Cash Flow Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.78% |
| Dec 31, 2025 | -4.72% |
| Sep 30, 2025 | 9.23% |
| Jun 30, 2025 | -1.90% |
| Mar 31, 2025 | -0.46% |
| Dec 31, 2024 | 2.77% |
| Sep 30, 2024 | 33.20% |
| Jun 30, 2024 | -60.18% |
| Mar 31, 2024 | 32.19% |
| Dec 31, 2023 | -10.00% |
| Sep 30, 2023 | 27.78% |
| Jun 30, 2023 | 29.77% |
| Mar 31, 2023 | 30.88% |
| Dec 31, 2022 | 41.45% |
| Sep 30, 2022 | 44.69% |
| Jun 30, 2022 | 45.91% |
| Mar 31, 2022 | 28.52% |
| Dec 31, 2021 | 48.34% |
| Sep 30, 2021 | 76.02% |
| Jun 30, 2021 | -64.39% |
| Mar 31, 2021 | 101.67% |
| Dec 31, 2020 | 92.90% |
| Sep 30, 2020 | 65.30% |
| Jun 30, 2020 | 59.28% |
| Mar 31, 2020 | 40.22% |
| Dec 31, 2019 | 33.15% |
| Sep 30, 2019 | 39.07% |
| Jun 30, 2019 | 39.08% |
| Mar 31, 2019 | 29.22% |
| Dec 31, 2018 | 124.11% |
| Sep 30, 2018 | 67.49% |
| Jun 30, 2018 | 155.59% |
| Mar 31, 2018 | 36.34% |
| Dec 31, 2017 | 71.29% |
| Sep 30, 2017 | 10.94% |
| Jun 30, 2017 | 9.82% |
| Mar 31, 2017 | 140.59% |
| Dec 31, 2016 | -23.45% |
| Sep 30, 2016 | 9.49% |